Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | BP1001 |
| Trade Name | |
| Synonyms | Prexigebersen |
| Drug Descriptions |
Prexigebersen (BP1001) is a liposome-incorporated antisense oligo targeting the Grb2 mRNA that inhibits Grb2 expression, resulting in growth inhibition in tumor cells (PMID: 29550383). |
| DrugClasses | |
| CAS Registry Number | 202484-91-1 |
| NCIT ID | C91736 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| BP1001 | BP1001 | 0 | 0 |
| BP1001 + Cytarabine | BP1001 Cytarabine | 0 | 0 |
| BP1001 + Dasatinib | BP1001 Dasatinib | 0 | 1 |
| BP1001 + Decitabine | BP1001 Decitabine | 0 | 1 |
| BP1001 + Decitabine + Venetoclax | BP1001 Decitabine Venetoclax | 0 | 1 |